United States of America – September 11, 2025 – The Insight Partners is proud to announce its newest market report, “Virology Market: An In-depth Analysis of Growth, Opportunities, and Trends 2021–2028”. The report provides a holistic view of the Virology Market and describes the current scenario as well as growth estimates during the forecast period.

Download Sample PDF Copy https://www.theinsightpartners.com/sample/TIPRE00006886/

Overview of Virology Market

The Virology Market is projected to reach US$ 5,276.48 million by 2028 from US$ 4,108.27 million in 2021, and it is expected to register a CAGR of 3.6% from 2021 to 2028. The market growth is driven by rising cases of viral infections, growing demand for advanced diagnostic solutions, and the continuous development of antiviral therapies.

Key Findings and Insights

Market Size and Growth

  • Forecast: The virology market will expand steadily through 2028, fueled by an increased focus on managing infectious diseases globally.
  • Key Growth Drivers: Advancements in molecular diagnostics, government-funded research on emerging viral diseases, and rising healthcare investments in virology-related therapeutics.

Virology Market Segmentation

By Type

  • Diagnostic Test
  • Viral Infection Controlling Techniques
  • Antiviral Therapeutics
  • Interferons

By Application

  • Skin and Soft Tissue Infections
  • Respiratory Tract Infections
  • GI Tract Infections
  • Sexually Transmitted Diseases
  • Urinary Tract Infection

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical and Biotechnological Companies
  • Research and Academic Institutes

Spotting Emerging Trends

  • Technological Advancements: Growth of PCR-based testing, next-generation sequencing (NGS), and AI-powered viral diagnostics.
  • Changing Consumer Preferences: Increasing demand for rapid, point-of-care testing to enable faster treatment decisions.
  • Regulatory Changes: Stronger regulatory frameworks promoting faster approvals of vaccines and antivirals in response to emerging viral outbreaks.

Growth Opportunities

The virology market presents opportunities in:

  • Expansion of diagnostic capabilities in developing nations.
  • Growing R&D in personalized antiviral therapies.
  • Increased collaborations between governments, biotech companies, and research institutes to combat viral epidemics.
  • Rising focus on precision medicine and targeted therapies for viral infections.

Market Leaders and Key Company Profiles

  • Abbott
  • Johnson & Johnson Services, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • QIAGEN
  • Illumina, Inc.
  • Siemens AG
  • GlaxoSmithKline Plc
  • AbbVie Inc.

Conclusion

The Virology Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2021–2028 report provides critical insights for organizations seeking to establish or expand their operations in this sector. With comprehensive analysis of market drivers, trends, and competitive landscapes, stakeholders can leverage fact-based insights to enhance strategies and seize new opportunities.

About Us

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in biotechnology, healthcare IT, pharmaceuticals, medical devices, and other high-growth sectors.

Contact Us

Contact Person: Ankit Mathur
E-mail: [email protected]
Phone: +1-646-491-9876

Also Available in: 日本 | 한국어 | Français | لعربية | 中文 | Italiano | Español | Deutsch